Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Sealbond Ltd — Dogwood Therapeutics, Inc. insider · InsiderLens

/ / Sealbond Ltd

Sealbond Ltd

10% owner at Dogwood Therapeutics, Inc. · on record since Oct 17, 2024
Director at Dogwood Therapeutics, Inc. · on record since Nov 25, 2025
See Remarks at Dogwood Therapeutics, Inc. · on record since Nov 25, 2025

Insider trading activity of Sealbond Ltd

No transactions on record for Sealbond Ltd.

Track record of Sealbond Ltd

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Sealbond Ltd

Co-insiders of Sealbond Ltd

Burch Richard AlanDogwood Therapeutics, Inc.
CK Life Sciences Intl (Holdings) IncDogwood Therapeutics, Inc.
Conjoint Inc.Dogwood Therapeutics, Inc.
De La Rosa AbelDogwood Therapeutics, Inc.
Duncan Gregory ScottDogwood Therapeutics, Inc.
Gendreau Roger MichaelDogwood Therapeutics, Inc.
Grosswald RalphDogwood Therapeutics, Inc.
Keefer David RDogwood Therapeutics, Inc.
Pridgen WilliamDogwood Therapeutics, Inc.
Thomas John CDogwood Therapeutics, Inc.
Toh Kean Meng MelvinDogwood Therapeutics, Inc.
Walsh AngelaDogwood Therapeutics, Inc.
Whitley Richard JamesDogwood Therapeutics, Inc.
Yu Ying Choi Alan AbelDogwood Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters